Enliven (ELVN) is up 11.0%, or $3.92 to $39.45.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ELVN:
- Enliven price target raised to $56 from $48 at H.C. Wainwright
- Clear Street says Merck’s bet on TERN-701 sharpens investment case for ELVN-001
- Video: Arm jumps as analysts react favorably to business model shift, guidance
- Enliven up 20% after Terns Pharmaceuticals agrees to be bought by Merck
- Enliven price target raised to $45 from $41 at Mizuho